Expression of MDR1, HIF-1 and MRP1 in sacral chordoma and chordoma cell line CM-319

Abstract

Background: Chordoma was a typically slow-growing tumor. The therapeutic approach to chordoma had traditionally relied mainly on surgical therapy. And the main reason for therapeutic failure was resistance to chemotherapy and radiotherapy. However the refractory mechanism was not clear. The aim of this study was to investigate the expression of three genes (MDR1, HIF-1 and MRP1) associated with resistance to chemotherapy and radiotherapy in chordoma and chordoma cell line CM-319. Materials and methods. Using immunohistochemical techniques, the expression of MDR1, HIF-1 and MRP1 was investigated in 50 chordoma specimen. Using RT-PCR and Western blot, the expression of MDR1, HIF-1 and MRP1 was investigated in chordoma and chordoma cell line CM-319. Results. Expression of MDR1, HIF-1 and MRP1 was observed in 10%, 80% and 74% of all cases, respectively. Expression of MRP1 was correlated with HIF-1. On the other hand, expression of MDR1 was not correlated with the expression of HIF-1 or MRP1. The expression of HIF-1 and MRP1 was observed, but MDR1 was not observed in chordoma and CM-319. Conclusion. Expression of HIF-1 and MRP1 was observed in most chordoma specimen and CM-319 cell line; expression of HIF-1 correlated with MRP1. HIF-1 and MRP1 may play a role in the multidrug resistance of chordoma to chemotherapy. © 2010 Ji et al; licensee BioMed Central Ltd.